基础医学与临床 ›› 2014, Vol. 34 ›› Issue (8): 1125-1128.

• 短篇综述 • 上一篇    下一篇

Nrf2/ARE/HO-1通路是治疗帕金森病的作用新靶点

王玉敏1,崔其福1,赵伟丽1,张俊毅1,王洪权2   

  1. 1. 赤峰学院附属医院
    2. 赤峰学院(附属医院)
  • 收稿日期:2013-10-23 修回日期:2013-12-23 出版日期:2014-08-05 发布日期:2014-07-15
  • 通讯作者: 王洪权 E-mail:whongquan@aliyun.com
  • 基金资助:
    国家自然科学基金(地区基金);内蒙古教育厅青年科技英才支持计划;内蒙古自治区高等学校科学技术重点研究项目

Nrf2/ARE/HO-1 signaling pathway is a new neuroprotective target for Parkinson’s disease

  • Received:2013-10-23 Revised:2013-12-23 Online:2014-08-05 Published:2014-07-15
  • Contact: Hongquan Wang E-mail:whongquan@aliyun.com

摘要: 调节Nrf2/ARE/HO-1通路在氧化应激相关性疾病中具有神经保护作用。通过药理学途径调节Nrf2/ARE/HO-1通路,可以抑制PD神经毒剂诱导的神经毒性损伤。因此,筛选调节此通路的化合物有可能成为治疗PD潜在的新靶点。

关键词: Nrf2, 血红素加氧酶-1, 帕金森病, 神经保护

Abstract: Recent studies have shown that regulation of Nrf2/ARE/HO-1 confer neuroprotection against oxidative stress-induced neurotoxicity. The specific activation of Nrf2/ARE/HO-1 gene expression by pharmacological modulation may represent a novel approach for therapeutic treatment of PD. There is, therefore, an excellent rationale for the development of new neuroprotective agents, based on their ability to enhance activity of Nrf2 and upregulate HO-1 expression.

Key words: Nrf2, Heme oxygenase-1, Parkinson’s disease, Neuroprotection

中图分类号: